2021 annual financial data
Puma Biotechnology Inc 2021 Operating margin
Puma Biotechnology Inc 2021 operating margin with verified reported values.
Direct answer
Operating margin was 0.51%.
Operating income was 1,290,000 USD and net income was -29,126,000 USD.
Operating cash flow was 20,650,000 USD.
Get free Puma Biotechnology Inc email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 253,155,000 USD
- Operating income
- 1,290,000 USD
- Net income
- -29,126,000 USD
- Operating cash flow
- 20,650,000 USD